The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach
| Autor: | Bos, J.M., Rietveld, E., Moll, H.A., Steyerberg, E.W., Luytjes, W., Wilschut, J.C., de Groot, R., Postma, M.J. |
|---|---|
| Zdroj: | In Vaccine 2007 25(39):6922-6929 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect